Related Experiment Video

Updated: Jul 17, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Hepatitis C treatment of patients with bipolar disorder: a case series

Muhamad Aly Rifai1

  • 1Office of the Clinical Director, National Institute of Mental Health, National Institutes of Health, Bethesda, Md, USA. AlyRifai@mail.nih.gov

Primary Care Companion to the Journal of Clinical Psychiatry
|January 25, 2007
PubMed

Insights

Hepatitis C (HCV) antiviral treatment can be effective for bipolar disorder patients, but requires careful monitoring for potential neuropsychiatric side effects. Meticulous assessment and extensive follow-up are crucial for successful outcomes in managing comorbid HCV and bipolar disorder.

Area of Science:

  • Hepatology
  • Psychiatry
  • Infectious Diseases

Background:

  • Comorbid Hepatitis C virus (HCV) infection affects 10-15% of bipolar disorder patients.
  • Managing patients with both HCV and bipolar disorder presents significant clinical challenges.
  • This report highlights critical issues in treating this complex patient population.

Purpose of the Study:

  • To evaluate the safety and efficacy of interferon-alpha-based therapies and ribavirin in patients with comorbid HCV and bipolar disorder.
  • To illustrate the challenges and considerations in managing HCV antiviral treatment in patients with psychiatric comorbidities.
  • To inform clinical decision-making regarding HCV treatment in bipolar disorder patients.

Main Methods:

  • Case series describing five patients with DSM-IV bipolar disorder treated for HCV.
  • Treatment involved interferon-alpha-based therapies and ribavirin under an integrated care model.
  • Treatment decisions were made by consensus between hepatologists and psychiatrists.

Main Results:

  • One patient achieved viral clearance without significant neuropsychiatric adverse effects.
  • Two patients achieved HCV viral clearance with careful management of interferon-alpha and ribavirin-induced affective symptoms.
  • Two patients discontinued treatment due to mania and suicidal ideation.

Conclusions:

  • HCV patients with bipolar disorder can tolerate antiviral treatments with meticulous assessment and close monitoring.
  • Integrated care and careful management are essential for managing neuropsychiatric side effects.
  • Further dialogue is needed on when to withhold or delay HCV antiviral treatment in these complex cases.
Abstract

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: